CCT241533 50mg 50mg | Purity Not Available
Adooq Bioscience
CCT241533 is a potent and selective Inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitors.
More Information Supplier PageCCT241533 is a potent and selective Inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitors.
More Information Supplier PageCCT241533 is a potent and selective Inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitors.
More Information Supplier PageCCT241533 is a potent and selective Inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitors.
More Information Supplier PageCCT241533 is a potent and selective Inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitors.
More Information Supplier PageGW791343 HCl acts as a negative allosteric modulator of human P2X7 (pIC50 = 6.9 – 7.2) and a positive allosteric modulator of rat P2X7.
More Information Supplier PageGW791343 HCl acts as a negative allosteric modulator of human P2X7 (pIC50 = 6.9 – 7.2) and a positive allosteric modulator of rat P2X7.
More Information Supplier PageGW791343 HCl acts as a negative allosteric modulator of human P2X7 (pIC50 = 6.9 – 7.2) and a positive allosteric modulator of rat P2X7.
More Information Supplier PageGW791343 HCl acts as a negative allosteric modulator of human P2X7 (pIC50 = 6.9 – 7.2) and a positive allosteric modulator of rat P2X7.
More Information Supplier PageCanagliflozin is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2).
More Information Supplier Page